Literature DB >> 32097652

Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.

Anand Vasudevan1, Prasamit S Baruah1, Joan C Smith2, Zihua Wang1, Nicole M Sayles3, Peter Andrews1, Jude Kendall1, Justin Leu1, Narendra Kumar Chunduri4, Dan Levy1, Michael Wigler1, Zuzana Storchová4, Jason M Sheltzer5.   

Abstract

High levels of cancer aneuploidy are frequently associated with poor prognosis. To examine the relationship between aneuploidy and cancer progression, we analyzed a series of congenic cell lines that harbor single extra chromosomes. We found that across 13 different trisomic cell lines, 12 trisomies suppressed invasiveness or were largely neutral, while a single trisomy increased metastatic behavior by triggering a partial epithelial-mesenchymal transition. In contrast, we discovered that chromosomal instability activates cGAS/STING signaling but strongly suppresses invasiveness. By analyzing patient copy-number data, we demonstrate that specific aneuploidies are associated with distinct outcomes, and the acquisition of certain aneuploidies is in fact linked with a favorable prognosis. Thus, aneuploidy is not a uniform driver of malignancy, and different aneuploidies can uniquely influence tumor progression. At the same time, the gain of a single chromosome is capable of inducing a profound cell state transition, thereby linking genomic plasticity, phenotypic plasticity, and metastasis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMT; aneuploidy; cGAS/STING; chromosome missegregation; copy number variation; metastasis

Mesh:

Substances:

Year:  2020        PMID: 32097652      PMCID: PMC7354079          DOI: 10.1016/j.devcel.2020.01.034

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  68 in total

1.  Transcriptional consequences of aneuploidy.

Authors:  Jason M Sheltzer; Eduardo M Torres; Maitreya J Dunham; Angelika Amon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 2.  Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.

Authors:  D E Merkel; W L McGuire
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

3.  Comprehensive Characterization of Cancer Driver Genes and Mutations.

Authors:  Matthew H Bailey; Collin Tokheim; Eduard Porta-Pardo; Sohini Sengupta; Denis Bertrand; Amila Weerasinghe; Antonio Colaprico; Michael C Wendl; Jaegil Kim; Brendan Reardon; Patrick Kwok-Shing Ng; Kang Jin Jeong; Song Cao; Zixing Wang; Jianjiong Gao; Qingsong Gao; Fang Wang; Eric Minwei Liu; Loris Mularoni; Carlota Rubio-Perez; Niranjan Nagarajan; Isidro Cortés-Ciriano; Daniel Cui Zhou; Wen-Wei Liang; Julian M Hess; Venkata D Yellapantula; David Tamborero; Abel Gonzalez-Perez; Chayaporn Suphavilai; Jia Yu Ko; Ekta Khurana; Peter J Park; Eliezer M Van Allen; Han Liang; Michael S Lawrence; Adam Godzik; Nuria Lopez-Bigas; Josh Stuart; David Wheeler; Gad Getz; Ken Chen; Alexander J Lazar; Gordon B Mills; Rachel Karchin; Li Ding
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

4.  Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.

Authors:  W E Glaab; K R Tindall
Journal:  Carcinogenesis       Date:  1997-01       Impact factor: 4.944

5.  Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.

Authors:  O P Kallioniemi; T Hietanen; J Mattila; M Lehtinen; K Lauslahti; T Koivula
Journal:  Eur J Cancer Clin Oncol       Date:  1987-03

6.  Absolute quantification of somatic DNA alterations in human cancer.

Authors:  Scott L Carter; Kristian Cibulskis; Elena Helman; Aaron McKenna; Hui Shen; Travis Zack; Peter W Laird; Robert C Onofrio; Wendy Winckler; Barbara A Weir; Rameen Beroukhim; David Pellman; Douglas A Levine; Eric S Lander; Matthew Meyerson; Gad Getz
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

7.  The presence of extra chromosomes leads to genomic instability.

Authors:  Verena Passerini; Efrat Ozeri-Galai; Mirjam S de Pagter; Neysan Donnelly; Sarah Schmalbrock; Wigard P Kloosterman; Batsheva Kerem; Zuzana Storchová
Journal:  Nat Commun       Date:  2016-02-15       Impact factor: 14.919

Review 8.  EMT and MET: necessary or permissive for metastasis?

Authors:  Mohit Kumar Jolly; Kathryn E Ware; Shivee Gilja; Jason A Somarelli; Herbert Levine
Journal:  Mol Oncol       Date:  2017-06-12       Impact factor: 6.603

9.  Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma.

Authors:  Yunyang Chen; Shaoming Li; Wei Li; Rongbing Yang; Xianguang Zhang; Yong Ye; Jiexiong Yu; Lin Ye; Wangrong Tang
Journal:  Sci Rep       Date:  2019-05-08       Impact factor: 4.379

10.  Unique features of the transcriptional response to model aneuploidy in human cells.

Authors:  Milena Dürrbaum; Anastasia Yurievna Kuznetsova; Verena Passerini; Silvia Stingele; Gabriele Stoehr; Zuzana Storchová
Journal:  BMC Genomics       Date:  2014-02-18       Impact factor: 3.969

View more
  16 in total

1.  Weighing up effects of extra chromosomes.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2020-05       Impact factor: 60.716

Review 2.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

3.  Extensive protein dosage compensation in aneuploid human cancers.

Authors:  Klaske M Schukken; Jason M Sheltzer
Journal:  Genome Res       Date:  2022-06-14       Impact factor: 9.438

4.  Quantifying chromosomal instability from intratumoral karyotype diversity using agent-based modeling and Bayesian inference.

Authors:  Andrew R Lynch; Nicholas L Arp; Amber S Zhou; Beth A Weaver; Mark E Burkard
Journal:  Elife       Date:  2022-04-05       Impact factor: 8.713

5.  Genome-wide identification and analysis of prognostic features in human cancers.

Authors:  Joan C Smith; Jason M Sheltzer
Journal:  Cell Rep       Date:  2022-03-29       Impact factor: 9.995

6.  Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division.

Authors:  John Michael Replogle; Wen Zhou; Adrianna E Amaro; James M McFarland; Mariana Villalobos-Ortiz; Jeremy Ryan; Anthony Letai; Omer Yilmaz; Jason Sheltzer; Stephen J Lippard; Uri Ben-David; Angelika Amon
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

Review 7.  miRNA dysregulation is an emerging modulator of genomic instability.

Authors:  Ana P Ferragut Cardoso; Mayukh Banerjee; Alexandra N Nail; Angeliki Lykoudi; J Christopher States
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

Review 8.  Aneuploidy as a promoter and suppressor of malignant growth.

Authors:  Anand Vasudevan; Klaske M Schukken; Erin L Sausville; Vishruth Girish; Oluwadamilare A Adebambo; Jason M Sheltzer
Journal:  Nat Rev Cancer       Date:  2021-01-11       Impact factor: 69.800

9.  Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway.

Authors:  Maria Krivega; Clara M Stiefel; Sahar Karbassi; Line L Andersen; Narendra K Chunduri; Neysan Donnelly; Andreas Pichlmair; Zuzana Storchová
Journal:  Commun Biol       Date:  2021-07-02

10.  Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies.

Authors:  Devon A Lukow; Erin L Sausville; Pavit Suri; Narendra Kumar Chunduri; Angela Wieland; Justin Leu; Joan C Smith; Vishruth Girish; Ankith A Kumar; Jude Kendall; Zihua Wang; Zuzana Storchova; Jason M Sheltzer
Journal:  Dev Cell       Date:  2021-08-04       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.